Federal health officials are reminding parents of infants to properly sterilize breast pump equipment after a baby died last year from a rare bacterial infection.
Spurred by the infant formula crisis, a panel found that the agency shied away from tough decisions, sometimes fearing confrontations with industry over enforcement of critical public health issues.
The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.